North Dakota Gets $923K in National Drug Suit
Johnson & Johnson is paying North Dakota $923,000 as part of a $1.2 billion national settlement over allegations it illegally promoted two of its best-selling antipsychotics drugs.
The state Department of Human Services says North Dakota's share of proceeds comes from a settlement announced last month by the U.S. Department of Justice. The lawsuit alleged civil and criminal violations by Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals.
The total settlement for North Dakota is about $3 million, with most of it going to the federal government, which pays for the majority of North Dakota's Medicaid program.
The Justice Department alleged that the company promoted powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.